Questions before booking? Text us at 561-216-7066
Beyond Concierge Healthcare logo Text or Call: 561-216-7066

Peptide Therapy · Learning Library

What Is PT-141 (Bremelanotide)? How It Affects Desire

An educational overview of PT-141, also called bremelanotide, how it acts on the brain's desire pathways and its FDA approval for women.

PT-141 (Bremelanotide) in short
  • PT-141, known by its generic name bremelanotide, is a lab-made peptide related to alpha-melanocyte stimulating hormone.
  • Bremelanotide activates melanocortin receptors, especially the MC4 receptor, in parts of the brain involved in sexual desire and arousal.
  • It has been studied in human clinical trials that led to its FDA approval for women.
  • Bremelanotide is FDA-approved, under the brand name Vyleesi, for premenopausal women with acquired, generalized low sexual desire that causes distress.

What PT-141 is

PT-141, known by its generic name bremelanotide, is a lab-made peptide related to alpha-melanocyte stimulating hormone. Unlike most treatments for sexual health, it works in the brain rather than on blood flow.

How it works in the body

  • Bremelanotide activates melanocortin receptors, especially the MC4 receptor, in parts of the brain involved in sexual desire and arousal.
  • That's a different pathway from medications that work on blood flow, which is why it's been studied for low desire rather than only physical function.

What it's commonly used for

Bremelanotide is FDA-approved, under the brand name Vyleesi, for premenopausal women with acquired, generalized low sexual desire that causes distress. People are also interested in it for libido in both women and men.

What the research shows

It has been studied in human clinical trials that led to its FDA approval for women. Research in men is smaller.

Safety and side effects

Common side effects include nausea, flushing and headache, and it can temporarily raise blood pressure, so it isn't a fit for everyone, especially people with heart conditions or uncontrolled blood pressure.

Talk it through with a provider

If you're curious whether peptides fit into your health goals, a licensed provider can look at your history and labs and talk through the evidence, the risks and your options.

Questions

PT-141 (Bremelanotide): frequently asked questions

What is PT-141 (Bremelanotide)?

PT-141, known by its generic name bremelanotide, is a lab-made peptide related to alpha-melanocyte stimulating hormone. Unlike most treatments for sexual health, it works in the brain rather than on blood flow.

How does PT-141 (Bremelanotide) work?

Bremelanotide activates melanocortin receptors, especially the MC4 receptor, in parts of the brain involved in sexual desire and arousal. That's a different pathway from medications that work on blood flow, which is why it's been studied for low desire rather than only physical function.

What is PT-141 (Bremelanotide) commonly used for?

Bremelanotide is FDA-approved, under the brand name Vyleesi, for premenopausal women with acquired, generalized low sexual desire that causes distress. People are also interested in it for libido in both women and men.

Is PT-141 (Bremelanotide) FDA-approved?

Yes, for one specific use. Bremelanotide is FDA-approved, under the brand name Vyleesi, for premenopausal women with acquired, generalized low sexual desire that causes distress. Other uses are off-label, so talk with a licensed provider before starting any treatment.

What are the side effects of PT-141 (Bremelanotide)?

Common side effects include nausea, flushing and headache, and it can temporarily raise blood pressure, so it isn't a fit for everyone, especially people with heart conditions or uncontrolled blood pressure.

This article is general education and isn't medical advice, and it isn't a recommendation to use any substance. Information about research and regulations can change. Talk with a licensed healthcare provider before starting any treatment.

CallText UsBook Now